Mar 6, 2014

Raindrop Digital PCR Installed


A Raindrop digital PCR system from Raindance has been intalled at the Genomics Core Facility.

A Billion Reactions. Digital Answers. Experience the Final Frontier of PCR.

The Raindrop digital PCR system is capable of generating more than a billion reactions in a single day, and surpasses all existing technologies, establishing a new performance standard in sensitivity, quantitation, and multiplexing. Based on RainDance’s proven picodroplet platform, the RainDrop System transforms the performance of molecular assays by enabling digital answers across a number of important applications including low-frequency tumor allele detection, gene expression, copy number variation, and SNP measurement.

 

Access to the instrument thropugh our reservation website. Training is requiered. 

For more information about the Raindrop

 
 
 
 
 
 


News

Jan 18, 2018

Due to a resent hacker attack to the OUS IT system, we currently are unable to receive or send emails to the rr-research domain. Until further notice please use this email to contact us “genomics.cf.oslo@gmail.com”

Feb 24, 2016

The HiSeq 4000 build upon the existing HiSeq 2500 platform using the new HiSeq X patterned flow cell technology, providing unparalleled speed and performance. The dual-flow cell HiSeq 4000 System delivers the highest throughput and lowest price per sample across multiple applications. The new sequencer will provide users will faster turnaround time (run time is 3 days compared to 6-11 days in HiSeq 2500) and higher quality, more data per run and longer reads (150 bp paired-end).


Contact Information:

genomics.cf.oslo@gmail.com

Visiting address:
Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

Daily Leader Core Facility
Susanne Lorenz, PhD

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

................................................................

................................................................